RXII

RXI Pharmaceuticals Corporation Press Releases

$0.41
*  
0.001
0.24%
Get RXII Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading RXII now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015
7/29/2015 7:02:00 AM - PR Newswire
▼-8.89 % Price Change since this news event. The Volume Ratio is 4.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform
6/9/2015 7:02:00 AM - PR Newswire
▼-12.77 % Price Change since this news event. The Volume Ratio is 1.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye
6/3/2015 7:02:00 AM - PR Newswire
▲10.81 % Price Change since this news event. The Volume Ratio is 1.32.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology
6/2/2015 7:02:00 AM - PR Newswire
▲7.89 % Price Change since this news event. The Volume Ratio is 0.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals' CEO Dr. Geert Cauwenbergh Interviewed by The Life Sciences Report
6/1/2015 7:02:00 AM - Market Wire
▲13.89 % Price Change since this news event. The Volume Ratio is 2.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants
5/28/2015 7:00:00 AM - PR Newswire
▲7.89 % Price Change since this news event. The Volume Ratio is 37.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
5/27/2015 4:10:00 PM - PR Newswire
▼-10.87 % Price Change since this news event. The Volume Ratio is 10.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock
5/27/2015 7:02:00 AM - PR Newswire
▼-10.87 % Price Change since this news event. The Volume Ratio is 12.11.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
5/26/2015 7:02:00 AM - PR Newswire
▼-18.00 % Price Change since this news event. The Volume Ratio is 12.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RXi Pharmaceuticals Reports First Quarter 2015 Financial Results and Business Highlights
5/13/2015 7:05:00 AM - PR Newswire
▼-29.31 % Price Change since this news event. The Volume Ratio is 1.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day